Skip to main content
. 2021 Feb 26;11:633420. doi: 10.3389/fonc.2021.633420

Figure 4.

Figure 4

Survival analyses of COL6A6 in lung adenocarcinoma (LUAD). (A) Association between COL6A6 expression and survival in LUAD based on GEPIA2 (group cutoff=quartile). (B) Association between COL6A6 expression and pathological stage by based on GEPIA2. (C) Survival meta-analysis of COL6A6 in LUAD by using the LCE web portal. (D) Kaplan–Meier survival curve for COL6A6 expression based on the TCGA-LUAD dataset (group cutoff=median). (E) Multivariate Cox analysis of COL6A6 expression and clinical characteristics. Up-regulated expression of COL6A6 and low pathological stage were independent predictors of favorable prognosis.